Cardiovascular disease

Increasing the chance of survival and reducing complications for patients undergoing cardiac surgery.

We develop interventions to prevent or treat complications in cardiac surgery patients of all ages. This includes severe bleeding, kidney damage and neurological complications as well as reducing the time they will have to spend in intensive care after surgery. We also engineer new types of vascular grafts with the ability to grow. This extends the lifespan of grafts, reducing the number of times a child may have to undergo heart surgery for correction of an inherited heart defect.

Workstreams

Minimising surgical bleeding

Feasibility studies for treatments and point of care testing

Avoiding acute kidney injury (AKI)

Predicting and treating post-operative kidney injury in adults and neonates

Avoiding neurological complications

Identifying markers and evaluating interventions and protective devices

Avoiding prolonged ventilation

Investigating the role of stress hormones in the peri-operative period

Enhanced longevity of heart valves and vascular conduits

Using stem cells technology to develop the next generation of cardiac grafts and prostheses

 

Understanding and predicting complications of cardiac surgery

Using large-scale data to investigate whether metabolic and genetic factors can help predict cardiac surgery complications

Get in touch

Academic Lead

ThemeĀ  Manager

Latest research news

Prehabilitation to improve outcomes after major elective surgery: a systematic review and meta-analysis

12 October 2021

Interventions such as eating foods that promote a strong immune system and exercises that strengthen ...

Study highlights stark inequality in survival after cardiac surgery between paying and NHS patients

16 December 2020

A new study has revealed paying patients are 20 per cent less likely to die ...